FSD Pharma & Canntab Rank Among the Top 2018 Cannabis Stocks
There is a lot more to cannabis stocks than share performance however share performance is critical when a company is at its beginning stages.
Tag: C.PILL
2018 Top Performing Cannabis Stocks
An interesting chart with the top performing cannabis stocks of 2018:
Canntab: All about the Cannabis Pill
The Canadian Cannabis market peaked – using the Canadian Marijuana Index – in early January of 2018. The Index topped 1000. It dropped a bit from there and, the Monday before legalization on Wednesday, October 17, touched 858. The index is now hovering around 500. Reality has caught up with the recreational marijuana business and the market caps of many of the producer stocks are adjusting downward to reflect that reality.
Canntab on Investment Pitch
A good, short, video overview of Cantab Therapeutics (C.PILL) on Investment Pitch.
Cannabis: Rec or Pharma
Tomorrow is legalization day in Canada. Saying that Canada is not ready for legalization is not quite right. Canada is, its governments are not. Apparently there will ba one fully licenced “legal” marijuana store in BC. None in Ontario. But there will be plenty of pot.
Canntab Therapeutics: Cannabis in a Hard Pill
Jeff Renwick and Richard Goldstein (l&r above) have been working together on the generic side of the pharmaceutical business for a decade. Developing drugs and drug delivery systems. Renwick has a total of 25 years in pharma and Goldstein was an investment banker. Their private company had two generic drugs in the pipeline and a good deal of work on extended release formulations.